OBCI
Income statement / Annual
Last year (2021), Ocean Bio-Chem, Inc.'s total revenue was $64.30 M,
an increase of 15.73% from the previous year.
In 2021, Ocean Bio-Chem, Inc.'s net income was $13.02 M.
See Ocean Bio-Chem, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
FY-2012
|
| Period Ended |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
12/31/2012 |
| Operating Revenue |
$64.30 M
|
$55.56 M
|
$42.26 M
|
$41.80 M
|
$38.93 M
|
$36.21 M
|
$33.99 M
|
$33.93 M
|
$32.70 M
|
$31.04 M
|
| Cost of Revenue |
$40.00 M |
$32.06 M |
$26.66 M |
$27.40 M |
$24.44 M |
$22.33 M |
$22.65 M |
$21.80 M |
$21.81 M |
$20.41 M |
| Gross Profit |
$24.30 M |
$23.50 M |
$15.60 M |
$14.40 M |
$14.50 M |
$13.87 M |
$11.34 M |
$12.13 M |
$10.89 M |
$10.63 M |
| Gross Profit Ratio |
0.38 |
0.42 |
0.37 |
0.34 |
0.37 |
0.38 |
0.33 |
0.36 |
0.33 |
0.34 |
| Research and Development
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$7.30 M
|
$7.66 M
|
$7.58 M
|
$6.54 M
|
$5.93 M
|
$5.13 M
|
| Selling & Marketing
Expenses |
$4.03 M
|
$11.34 M
|
$10.99 M
|
$10.69 M
|
$10.82 M
|
$10.78 M
|
$10.59 M
|
$9.11 M
|
$8.58 M
|
$7.54 M
|
| Selling, General &
Administrative Expenses |
$4.03 M
|
$11.34 M
|
$10.99 M
|
$10.69 M
|
$18.12 M
|
$18.44 M
|
$18.17 M
|
$15.65 M
|
$14.51 M
|
$12.67 M
|
| Other Expenses |
$13.44 M |
$0.00 |
$0.00 |
$0.00 |
-$7.30 M |
-$7.66 M |
-$7.58 M |
-$6.54 M |
-$5.93 M |
-$5.13 M |
| Operating Expenses |
$13.44 M |
$11.34 M |
$10.99 M |
$10.69 M |
$10.82 M |
$10.78 M |
$10.59 M |
$9.11 M |
$8.58 M |
$7.54 M |
| Cost And Expenses |
$53.44 M |
$43.40 M |
$37.65 M |
$38.09 M |
$35.26 M |
$33.11 M |
$33.24 M |
$30.90 M |
$30.39 M |
$27.96 M |
| Interest Income |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$148,580.00 |
$132,466.00 |
-$118,642.00 |
-$121,894.00 |
$2,065.00 |
$17,820.00 |
$33,639.00 |
$43,454.00 |
$67,180.00 |
$97,964.00 |
| Depreciation &
Amortization |
$1.49 M
|
$1.37 M
|
$1.29 M
|
$1.18 M
|
$955,161.00
|
$974,587.00
|
$916,317.00
|
$843,116.00
|
$782,962.00
|
$701,569.00
|
| EBITDA |
$7.74 M
|
$13.74 M
|
$5.78 M
|
$4.76 M
|
$4.63 M
|
$4.07 M
|
$1.65 M
|
$3.88 M
|
$3.13 M
|
$3.82 M
|
| EBITDA Ratio |
0.12 |
0.25 |
0.14 |
0.11 |
0.12 |
0.11 |
0.05 |
0.11 |
0.1 |
0.12 |
| Operating Income Ratio
|
0.17
|
0.22
|
0.11
|
0.09
|
0.09
|
0.09
|
0.02
|
0.09
|
0.07
|
0.1
|
| Total Other
Income/Expenses Net |
-$4.61 M
|
$68,744.00
|
-$118,642.00
|
-$121,894.00
|
$2,065.00
|
-$17,820.00
|
-$46,161.00
|
-$43,454.00
|
-$850,949.00
|
-$1.12 M
|
| Income Before Tax |
$10.71 M |
$12.23 M |
$4.49 M |
$3.59 M |
$3.68 M |
$3.08 M |
$703,370.00 |
$2.98 M |
$2.25 M |
$2.99 M |
| Income Before Tax Ratio
|
0.17
|
0.22
|
0.11
|
0.09
|
0.09
|
0.09
|
0.02
|
0.09
|
0.07
|
0.1
|
| Income Tax Expense |
-$2.31 M |
$2.62 M |
$996,004.00 |
$791,030.00 |
$1.07 M |
$983,151.00 |
$242,676.00 |
$948,874.00 |
$815,812.00 |
$1.06 M |
| Net Income |
$13.02 M |
$9.62 M |
$3.50 M |
$2.80 M |
$2.60 M |
$2.10 M |
$460,694.00 |
$2.05 M |
$1.46 M |
$1.96 M |
| Net Income Ratio |
0.2 |
0.17 |
0.08 |
0.07 |
0.07 |
0.06 |
0.01 |
0.06 |
0.04 |
0.06 |
| EPS |
1.37 |
1.02 |
0.37 |
0.3 |
0.28 |
0.23 |
0.0515 |
0.23 |
0.17 |
0.24 |
| EPS Diluted |
1.37 |
1.02 |
0.37 |
0.3 |
0.28 |
0.23 |
0.051 |
0.23 |
0.17 |
0.23 |
| Weighted Average Shares
Out |
$9.49 M
|
$9.46 M
|
$9.40 M
|
$9.32 M
|
$9.19 M
|
$9.06 M
|
$8.94 M
|
$8.83 M
|
$8.54 M
|
$8.23 M
|
| Weighted Average Shares
Out Diluted |
$9.49 M
|
$9.46 M
|
$9.40 M
|
$9.32 M
|
$9.25 M
|
$9.12 M
|
$9.03 M
|
$8.95 M
|
$8.79 M
|
$8.56 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
